These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 1725040)
1. Treatment of hypertension: a clinical epidemiologist's view. Poulter NR J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S35-8. PubMed ID: 1725040 [TBL] [Abstract][Full Text] [Related]
2. Thiazide diuretics in the treatment of hypertension: an update. Salvetti A; Ghiadoni L J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S25-9. PubMed ID: 16565243 [TBL] [Abstract][Full Text] [Related]
3. Implications of the primary prevention trials against coronary heart disease. Kannel WB J Hypertens Suppl; 1990 Dec; 8(7):S245-50. PubMed ID: 1982770 [TBL] [Abstract][Full Text] [Related]
4. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome. Leenen FH Can J Cardiol; 2004 Aug; 20 Suppl B():77B-82B. PubMed ID: 15309209 [TBL] [Abstract][Full Text] [Related]
5. The diuretic dilemma and the management of mild hypertension. Moser M J Clin Hypertens; 1986 Jun; 2(2):195-202. PubMed ID: 3531420 [TBL] [Abstract][Full Text] [Related]
6. [Retrospective studies and prospects of therapy for hypertension]. Maisch B; Brilla C; Kruse T; Noll B; Bethge C Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697 [TBL] [Abstract][Full Text] [Related]
7. Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration. J Hypertens; 1998 Feb; 16(2):127-37. PubMed ID: 9535138 [TBL] [Abstract][Full Text] [Related]
14. A review of stroke in patients with hypertension and coronary artery disease: Focus on calcium channel blockers. Bangalore S; Messerli FH Int J Clin Pract; 2006 Oct; 60(10):1281-6. PubMed ID: 16942591 [TBL] [Abstract][Full Text] [Related]
15. Classical risk factors and emerging elements in the risk profile for coronary artery disease. Gensini GF; Comeglio M; Colella A Eur Heart J; 1998 Feb; 19 Suppl A():A53-61. PubMed ID: 9519344 [TBL] [Abstract][Full Text] [Related]
16. Which drug should be used to treat patients with uncomplicated essential hypertension? Rashidi A; Rahman M; Wright JT Curr Opin Nephrol Hypertens; 2006 May; 15(3):303-8. PubMed ID: 16609299 [TBL] [Abstract][Full Text] [Related]
17. Balancing benefit against risk in the choice of therapy for coronary artery disease. Lesson from prospective, randomized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery. Morrison DA; Sacks J Minerva Cardioangiol; 2003 Oct; 51(5):585-97. PubMed ID: 14551526 [TBL] [Abstract][Full Text] [Related]
18. [Effect of alpha inhibitors on risk cofactors in patients with hypertension]. Plouin P Ann Cardiol Angeiol (Paris); 1989 Dec; 38(9 Pt 2):577-9; discussion 580. PubMed ID: 2576348 [TBL] [Abstract][Full Text] [Related]
19. [Hypertension management in general practice in Iceland]. Jensdóttir JO; Sigurethsson EL; Thornorgeirsson G Laeknabladid; 2006 May; 92(5):375-80. PubMed ID: 16741320 [TBL] [Abstract][Full Text] [Related]
20. [Cardiovascular risk factors and prevention in women: similarities and differences]. Sclavo M Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]